# | Title | Journal | Year | Citations |
---|
1 | The Pulmonary Hypertension Association Registry: Rationale, Design, and Role in Quality Improvement | Advances in Pulmonary Hypertension | 2018 | 23 |
2 | Modern Right Heart Catheterization: Beyond Simple Hemodynamics | Advances in Pulmonary Hypertension | 2020 | 22 |
3 | Diagnostic Dilemmas: Diastolic Heart Failure Causing Pulmonary Hypertension and Pulmonary Hypertension Causing Diastolic Dysfunction | Advances in Pulmonary Hypertension | 2006 | 18 |
4 | Atrial Septal Defect–Associated Pulmonary Hypertension: Outcomes of Closure With a Fenestrated Device | Advances in Pulmonary Hypertension | 2019 | 14 |
5 | Cardiac Catheterization in Pulmonary Arterial Hypertension: An Updated Guide to Proper Use | Advances in Pulmonary Hypertension | 2005 | 14 |
6 | Pulmonary Hypertension Care Centers | Advances in Pulmonary Hypertension | 2014 | 13 |
7 | Health-related Quality of Life in Pulmonary Arterial Hypertension | Advances in Pulmonary Hypertension | 2010 | 13 |
8 | High-Altitude Pulmonary Vascular Diseases | Advances in Pulmonary Hypertension | 2017 | 12 |
9 | Risk Assessment in Pulmonary Arterial Hypertension Patients: The Long and Short of it | Advances in Pulmonary Hypertension | 2018 | 12 |
10 | Liver Transplant Considerations and Outcomes for the Portopulmonary Hypertension Patient | Advances in Pulmonary Hypertension | 2004 | 11 |
11 | Facilitating Pulmonary Arterial Hypertension Medication Adherence: Patient-centered Management | Advances in Pulmonary Hypertension | 2010 | 11 |
12 | Pulmonary Hypertension Out of Proportion to Left Heart Disease | Advances in Pulmonary Hypertension | 2006 | 10 |
13 | Pulmonary Hypertension in Thalassemia: Association with Hemolysis, Arginine Metabolism Dysregulation, and a Hypercoagulable State | Advances in Pulmonary Hypertension | 2007 | 10 |
14 | Preoperative Risk Assessment of Pulmonary Arterial Hypertension Patients Undergoing General Surgery | Advances in Pulmonary Hypertension | 2007 | 10 |
15 | Cardiopulmonary Hemodynamics in Pulmonary Hypertension: Pressure Tracings, Waveforms, and More | Advances in Pulmonary Hypertension | 2008 | 10 |
16 | Pulmonary Vascular Response Patterns to Exercise: Is There a Role for Pulmonary Arterial Pressure Assessment During Exercise in the Post-Dana Point Era? | Advances in Pulmonary Hypertension | 2010 | 10 |
17 | Intraoperative Management of Patients with Pulmonary Hypertension | Advances in Pulmonary Hypertension | 2013 | 9 |
18 | Overview of WHO Group 2 Pulmonary Hypertension Due to Left Heart Disease | Advances in Pulmonary Hypertension | 2015 | 9 |
19 | Managing Right Ventricular Failure in PAH: An Algorithmic Approach | Advances in Pulmonary Hypertension | 2005 | 8 |
20 | The Nuts and Bolts of Interpreting Hemodynamics in Pulmonary Hypertension Associated With Diastolic Heart Failure | Advances in Pulmonary Hypertension | 2011 | 7 |
21 | Future Therapies in PAH: Update on the New Landscape and Drugs in the Pipeline | Advances in Pulmonary Hypertension | 2014 | 7 |
22 | Pulmonary Vascular Disease in Bronchopulmonary Dysplasia | Advances in Pulmonary Hypertension | 2016 | 7 |
23 | The Basic Science of Metabolism in Pulmonary Arterial Hypertension | Advances in Pulmonary Hypertension | 2018 | 7 |
24 | HIV-Associated Pulmonary Hypertension: A Global Perspective | Advances in Pulmonary Hypertension | 2017 | 6 |
25 | Update on the PHA Pulmonary Hypertension Care Center Network: Early Experience With the National Accreditation Program | Advances in Pulmonary Hypertension | 2018 | 6 |
26 | Palliative Care and Advance Care Planning in Pulmonary Hypertension | Advances in Pulmonary Hypertension | 2018 | 6 |
27 | Perioperative Management of PH: Covering All Aspects From Risk Assessment to Postoperative Considerations | Advances in Pulmonary Hypertension | 2005 | 6 |
28 | Hemolysis-Associated Endothelial Dysfunction and Pulmonary Hypertension, an Emerging Cause of Death in the Hemoglobinopathies | Advances in Pulmonary Hypertension | 2007 | 6 |
29 | Pulmonary Hypertension and Palliative Care: What, When, Where, and Why? | Advances in Pulmonary Hypertension | 2016 | 6 |
30 | Health Disparities in Pulmonary Arterial Hypertension and the Impact of the COVID-19 Pandemic | Advances in Pulmonary Hypertension | 2021 | 5 |
31 | A New Classification of Pulmonary Hypertension | Advances in Pulmonary Hypertension | 2002 | 5 |
32 | Pulmonary Arterial Hypertension: Epidemiology and Registries | Advances in Pulmonary Hypertension | 2014 | 5 |
33 | Perioperative Management of Pediatric Pulmonary Hypertension | Advances in Pulmonary Hypertension | 2016 | 5 |
34 | Pulmonary Vascular Diseases Secondary to Schistosomiasis | Advances in Pulmonary Hypertension | 2017 | 5 |
35 | Center-based Care for Pulmonary Hypertension: A European Perspective | Advances in Pulmonary Hypertension | 2018 | 5 |
36 | PH Professional Network: The Burden of Prior Authorization for Pulmonary Hypertension Medications: A Practical Guide for Managing the Process | Advances in Pulmonary Hypertension | 2018 | 5 |
37 | Treating Pulmonary Arterial Hypertension With Exercise: The Role of Rehabilitative Medicine | Advances in Pulmonary Hypertension | 2019 | 5 |
38 | Portopulmonary Hypertension: Understanding Pulmonary Hypertension in the Setting of Liver Disease | Advances in Pulmonary Hypertension | 2004 | 5 |
39 | Sickle Cell Disease-Associated Pulmonary Hypertension: Overview of Clinical Manifestations and Emerging Therapeutic Options | Advances in Pulmonary Hypertension | 2007 | 5 |
40 | Guidelines for the Prevention of Central Venous Catheter-Related Bloodstream Infections with Prostanoid Therapy for Pulmonary Arterial Hypertension | Advances in Pulmonary Hypertension | 2008 | 5 |
41 | What Can be Learned in 6 Minutes? 6-Minute Walk Test Primer and Role in Pulmonary Arterial Hypertension | Advances in Pulmonary Hypertension | 2010 | 5 |
42 | Clinical Trials Update | Advances in Pulmonary Hypertension | 2013 | 5 |
43 | Endothelin Receptor Antagonism: A New Era in the Treatment of Pulmonary Arterial Hypertension | Advances in Pulmonary Hypertension | 2002 | 4 |
44 | Cell Therapy for Pulmonary Arterial Hypertension: Potential Efficacy of Endothelial Progenitor Cells and Mesenchymal Stem Cells | Advances in Pulmonary Hypertension | 2012 | 4 |
45 | Sepsis and Pulmonary Arterial Hypertension in the ICU | Advances in Pulmonary Hypertension | 2015 | 4 |
46 | Calcium Channel Blocker Therapy: When a Drug Works, it Works. When it Doesn't, it Doesn't | Advances in Pulmonary Hypertension | 2017 | 4 |
47 | PH Professional Network: Comprehensive Evaluation and Ongoing Approach to Children With Down Syndrome Who Have Pulmonary Hypertension or Are at Risk of Developing Pulmonary Hypertension | Advances in Pulmonary Hypertension | 2019 | 4 |
48 | Chronic Thromboembolic Pulmonary Hypertension: When to Suspect It, When to Refer for Surgery | Advances in Pulmonary Hypertension | 2003 | 4 |
49 | The Serotonin Pathway in Pulmonary Hypertension | Advances in Pulmonary Hypertension | 2005 | 4 |
50 | Physical Examination in Pulmonary Arterial Hypertension | Advances in Pulmonary Hypertension | 2005 | 4 |